Kangmei Pharmaceutical Co., Ltd. (SHA:600518)

China flag China · Delayed Price · Currency is CNY
1.740
+0.030 (1.75%)
Apr 29, 2026, 11:29 AM CST
-10.77%
Market Cap 23.65B
Revenue (ttm) 5.25B
Net Income (ttm) 10.33M
Shares Out 13.83B
EPS (ttm) 0.00
PE Ratio 2,289.64
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 101,094,525
Average Volume 162,989,810
Open 1.710
Previous Close 1.710
Day's Range 1.710 - 1.740
52-Week Range 1.690 - 2.270
Beta 0.76
RSI 35.23
Earnings Date Apr 18, 2026

About Kangmei Pharmaceutical

Kangmei Pharmaceutical Co., Ltd. produces and sells Chinese herbal medicines in China. The company offers Chinese patent medicines, chemical medicines, and health food products. In addition, it engages in the operation of Chinese medicinal materials markets; production and sale of medical devices; and operation of pharmaceutical logistics system. The company provides its products through medical institution resources, smart pharmacies, OTC retail, chain drug stores, direct sales, medical e-commerce, mobile medical care, etc. Kangmei Pharmaceuti... [Read more]

Sector Healthcare
Founded 1997
Employees 4,233
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600518
Full Company Profile

Financial Performance

In 2025, Kangmei Pharmaceutical's revenue was 5.25 billion, an increase of 1.22% compared to the previous year's 5.19 billion. Earnings were 10.33 million, an increase of 20.46%.

Financial Statements

News

There is no news available yet.